GSK plc (GSK) ORD GBP0.3125
9.00p
(0.55%)
- Add to watchlist
- Create an alert
- This stock can be held in a
9.00p
(0.55%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
9.00p
(0.55%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Share news, reports & tips
-
GSK shingles vaccine approved for expanded use in China
14 October 2025 07:07
(Sharecast News) - Pharma giant GSK has received regulatory approval in China to expand the use of its Shingrix shingles vaccine, the company announced on Tuesday.
-
London midday: UK stocks keep grinding towards year's highs
3 October 2025 11:15
(Sharecast News) - Stocks are moving higher still shortly before midday with investor sentiment buoyed by fresh bullish news around the artificial intelligence space, even as investors keep a wary eye on the...
-
Emma Walmsley to step down as chief executive of GSK
29 September 2025 07:01
(Sharecast News) - Chief executive Emma Walmsley is to leave GSK, it was announced on Monday, after nearly a decade in the role.
-
Trump to impose tariffs of 100% on branded drug imports
26 September 2025 07:53
(Sharecast News) - Donald Trump is to impose tariffs of 100% on imports of pharmaceutical goods, it emerged on Friday, the latest salvo in the US president's global trade war.
-
GSK plans $30bn US investment as pharma faces tariff threat
17 September 2025 07:03
(Sharecast News) - GSK has announced plans to invest $30bn across the US in research and development and supply chain infrastructure over the next five years, amid fears of tariffs being imposed on the...
-
GSK gepotidacin edges closer to landmark approval for gonorrhoea
11 August 2025 07:15
(Sharecast News) - Drugmaker GSK moved closer to expanding its antibiotic portfolio on Monday, after US regulators accepted its application to review gepotidacin as a potential oral treatment for gonorrhoea.
-
GSK and CureVac secure $740m payout in mRNA patent settlement
8 August 2025 07:36
(Sharecast News) - Drugmaker GSK said on Friday that it had reached a settlement, alongside CureVac, to resolve long-running patent litigation with BioNTech and Pfizer over mRNA-based COVID-19 vaccines.
-
London close: Stocks fall on Trump's latest tariffs, US jobs data
1 August 2025 17:37
(Sharecast News) - London stocks ended the week lower on Friday as investors reacted to a fresh wave of US tariffs and disappointing economic data from the United States.
-
London close: Stocks mixed on robust US data, earnings flurry
30 July 2025 17:15
(Sharecast News) - London equities ended Wednesday narrowly mixed as investors weighed stronger-than-expected US economic data against a wave of corporate earnings that failed to inspire.
-
GSK Q2 revenues grow, expects FY performance to be top end of guidance
30 July 2025 07:36
(Sharecast News) - Drugmaker GSK said on Wednesday that Q2 revenues had grown as a strong specialty medicines performance drove sales and core operating profit growth.
-
London close: Stocks reverse gains to finish lower
28 July 2025 17:16
(Sharecast News) - London stocks ended lower on Monday, erasing earlier gains as investors reassessed the weekend's trade agreement between the United States and the European Union.
-
GSK and Hengrui unveil development deal worth up to $12bn
28 July 2025 07:17
(Sharecast News) - GSK has entered into a partnership with Chinese pharmaceutical outfit Hengrui Pharma to jointly develop up to 12 medicines, in a deal that could be worth up to $12bn.
Company announcements Announcements
-
Transaction in Own Shares
17 October 2025 07:00
GSK
-
Director/PDMR Shareholding
16 October 2025 15:30
GSK
-
Transaction in Own Shares
16 October 2025 07:00
GSK
-
Director/PDMR Shareholding
15 October 2025 15:30
GSK
-
Transaction in Own Shares
15 October 2025 07:00
GSK
-
GSK receives expanded Shingrix approval in China
14 October 2025 07:00
GSK
-
Transaction in Own Shares
14 October 2025 07:00
GSK
-
Director/PDMR Shareholding
13 October 2025 15:30
GSK
-
Transaction in Own Shares
13 October 2025 07:00
GSK
-
Director/PDMR Shareholding
10 October 2025 15:30
GSK
-
Transaction in Own Shares
10 October 2025 07:00
GSK
-
Transaction in Own Shares
9 October 2025 07:00
GSK
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.